Skip to main content
SpringerLink
Log in

Report of successful use of ustekinumab in Crohn’s disease refractory to three anti-TNF therapies

  • Letter to the Editor
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Reference

  1. Duerr RH, Taylor KD, Brant SR et al (2006) A genome-wide association study identifies IL-23R as an inflammatory bowel disease gene. Science 314(5804):1461–1463

    Article  CAS  PubMed  Google Scholar 

  2. Sandborn WJ, Feagan BG, Fedorak RN et al (2008) A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn’s disease. Gastroenterology 135(4):1130–1141

    Article  CAS  PubMed  Google Scholar 

  3. Toedter GP, Blank M, Lang Y et al (2009) Relationship of C-reactive protein with clinical response after therapy with ustekinumab in Crohn’s disease. Am J Gastroenterol 104(11):2768–2773

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

Dr. Heetun has nothing to disclose.

Author information

Authors and Affiliations

  1. Centre for Colorectal Disease, St Vincent’s University Hospital, Elm Park, Dublin 4, Ireland

    Z. S. Heetun, D. Keegan, D. O’Donoghue & G. A. Doherty

Authors
  1. Z. S. Heetun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Keegan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. O’Donoghue
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. A. Doherty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Z. S. Heetun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heetun, Z.S., Keegan, D., O’Donoghue, D. et al. Report of successful use of ustekinumab in Crohn’s disease refractory to three anti-TNF therapies. Ir J Med Sci 183, 507–508 (2014). https://doi.org/10.1007/s11845-014-1107-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-014-1107-2

Keywords

Search

Navigation